Medical cannabis for the treatment of fibromyalgia syndrome: a retrospective, open-label case series
Abstract Background The use of cannabis for treating fibromyalgia syndrome (FMS) has not been comprehensively investigated. Thus, we have assessed the efficacy and adverse events (AEs) of short- and long-term medical cannabis (MC) treatment for FMS. Methods Data were obtained from medical reports ar...
Saved in:
Main Author: | Manuela Mazza (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2021-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fibromyalgia Treatment Using Microphysiotherapy: An Open-Label Pilot Study
by: Tatiana Dias Rosa de Matos, et al.
Published: (2022) -
Integration with Spilanthes Achmella in fibromyalgia syndrome: open-label study six months after the treatment
by: Marco Bardelli, et al.
Published: (2021) -
Effectiveness and safety of cannabis-based products for medical use in patients with fibromyalgia syndrome: A systematic review
by: Valentina Lopera, et al.
Published: (2024) -
An Open-Label, Pilot Trial of HRG80™ Red Ginseng in Chronic Fatigue Syndrome, Fibromyalgia, and Post-Viral Fatigue
by: Jacob Teitelbaum, et al.
Published: (2021) -
Newer treatments for fibromyalgia syndrome
by: Richard E Harris, et al.
Published: (2008)